logo

For the Inventor, By the Inventor

Taejon, South Korea

Eu-Gene Oh

This inventor holds 4 USPTO granted patents. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2004-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eu-Gene Oh. Retrieved from https://idiyas.com/inventor/eu-gene-oh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal4 out of 132,108 
 
Samsung Electronics Co., Ltd.
 patents

Years Active: 2004-2009

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7511034 - Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses (2009-03-31),
2. 7229988 - Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses (2007-06-12),
3. 6949654 - N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses (2005-09-27),
4. 6815459 - Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses (2004-11-09),

Title: Eu-Gene Oh: Innovator in Therapeutic Compounds

Introduction

Eu-Gene Oh is a prominent inventor based in Taejon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds. With a total of 4 patents to his name, his work focuses on addressing critical medical issues.

Latest Patents

One of his latest patents involves dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses. These novel compounds are designed to treat and prevent various medical dysfunctions and diseases that arise from reactive oxygen species and excess zinc ions. Specifically, they target conditions such as stroke, Parkinson's disease, and Alzheimer's disease. The compounds exhibit low toxicity and demonstrate similar or superior lipid peroxidation (LPO) inhibition activity compared to existing references. Furthermore, they effectively inhibit cerebral neuronal cell death caused by reactive oxygen species and zinc ions, showcasing neuroprotective effects against ischemic neuronal degeneration.

Career Highlights

Eu-Gene Oh is currently associated with Samsung Electronics Co., Ltd., where he continues to innovate and develop therapeutic solutions. His work has garnered attention for its potential impact on treating neurodegenerative diseases.

Collaborations

He has collaborated with notable colleagues, including Sung-Bo Ko and Dennis W Choi, to advance his research and development efforts.

Conclusion

Eu-Gene Oh's contributions to the field of medicinal chemistry highlight his commitment to improving health outcomes through innovative therapeutic compounds. His work continues to pave the way for advancements in treating serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…